Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Measles Vaccine market report explains the definition, types, applications, major countries, and major players of the Measles Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Medimmune
CSL Limited
GSK
Novartis
Bavarian Nordic
Merck
Pfizer
Serum Institute of India
China National Biotech Group
Emergent Biosolutions
Sanofi-Pasteur
Johnson & Johnson
By Type:
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
By End-User:
Children
Adults
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Measles Vaccine Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Measles Vaccine Outlook to 2028- Original Forecasts
-
2.2 Measles Vaccine Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Measles Vaccine Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Measles Vaccine Market- Recent Developments
-
6.1 Measles Vaccine Market News and Developments
-
6.2 Measles Vaccine Market Deals Landscape
7 Measles Vaccine Raw Materials and Cost Structure Analysis
-
7.1 Measles Vaccine Key Raw Materials
-
7.2 Measles Vaccine Price Trend of Key Raw Materials
-
7.3 Measles Vaccine Key Suppliers of Raw Materials
-
7.4 Measles Vaccine Market Concentration Rate of Raw Materials
-
7.5 Measles Vaccine Cost Structure Analysis
-
7.5.1 Measles Vaccine Raw Materials Analysis
-
7.5.2 Measles Vaccine Labor Cost Analysis
-
7.5.3 Measles Vaccine Manufacturing Expenses Analysis
8 Global Measles Vaccine Import and Export Analysis (Top 10 Countries)
-
8.1 Global Measles Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Measles Vaccine Export by Region (Top 10 Countries) (2017-2028)
9 Global Measles Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Measles Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Mumps Measles Rubella Vaccine, Live (MMR-II) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Consumption and Growth Rate (2017-2022)
-
9.2 Global Measles Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Children Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adults Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Measles Vaccine Market Analysis and Outlook till 2022
-
10.1 Global Measles Vaccine Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Measles Vaccine Consumption (2017-2022)
-
10.2.2 Canada Measles Vaccine Consumption (2017-2022)
-
10.2.3 Mexico Measles Vaccine Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Measles Vaccine Consumption (2017-2022)
-
10.3.2 UK Measles Vaccine Consumption (2017-2022)
-
10.3.3 Spain Measles Vaccine Consumption (2017-2022)
-
10.3.4 Belgium Measles Vaccine Consumption (2017-2022)
-
10.3.5 France Measles Vaccine Consumption (2017-2022)
-
10.3.6 Italy Measles Vaccine Consumption (2017-2022)
-
10.3.7 Denmark Measles Vaccine Consumption (2017-2022)
-
10.3.8 Finland Measles Vaccine Consumption (2017-2022)
-
10.3.9 Norway Measles Vaccine Consumption (2017-2022)
-
10.3.10 Sweden Measles Vaccine Consumption (2017-2022)
-
10.3.11 Poland Measles Vaccine Consumption (2017-2022)
-
10.3.12 Russia Measles Vaccine Consumption (2017-2022)
-
10.3.13 Turkey Measles Vaccine Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Measles Vaccine Consumption (2017-2022)
-
10.4.2 Japan Measles Vaccine Consumption (2017-2022)
-
10.4.3 India Measles Vaccine Consumption (2017-2022)
-
10.4.4 South Korea Measles Vaccine Consumption (2017-2022)
-
10.4.5 Pakistan Measles Vaccine Consumption (2017-2022)
-
10.4.6 Bangladesh Measles Vaccine Consumption (2017-2022)
-
10.4.7 Indonesia Measles Vaccine Consumption (2017-2022)
-
10.4.8 Thailand Measles Vaccine Consumption (2017-2022)
-
10.4.9 Singapore Measles Vaccine Consumption (2017-2022)
-
10.4.10 Malaysia Measles Vaccine Consumption (2017-2022)
-
10.4.11 Philippines Measles Vaccine Consumption (2017-2022)
-
10.4.12 Vietnam Measles Vaccine Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Measles Vaccine Consumption (2017-2022)
-
10.5.2 Colombia Measles Vaccine Consumption (2017-2022)
-
10.5.3 Chile Measles Vaccine Consumption (2017-2022)
-
10.5.4 Argentina Measles Vaccine Consumption (2017-2022)
-
10.5.5 Venezuela Measles Vaccine Consumption (2017-2022)
-
10.5.6 Peru Measles Vaccine Consumption (2017-2022)
-
10.5.7 Puerto Rico Measles Vaccine Consumption (2017-2022)
-
10.5.8 Ecuador Measles Vaccine Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Measles Vaccine Consumption (2017-2022)
-
10.6.2 Kuwait Measles Vaccine Consumption (2017-2022)
-
10.6.3 Oman Measles Vaccine Consumption (2017-2022)
-
10.6.4 Qatar Measles Vaccine Consumption (2017-2022)
-
10.6.5 Saudi Arabia Measles Vaccine Consumption (2017-2022)
-
10.6.6 United Arab Emirates Measles Vaccine Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Measles Vaccine Consumption (2017-2022)
-
10.7.2 South Africa Measles Vaccine Consumption (2017-2022)
-
10.7.3 Egypt Measles Vaccine Consumption (2017-2022)
-
10.7.4 Algeria Measles Vaccine Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Measles Vaccine Consumption (2017-2022)
-
10.8.2 New Zealand Measles Vaccine Consumption (2017-2022)
11 Global Measles Vaccine Competitive Analysis
-
11.1 Medimmune
-
11.1.1 Medimmune Company Details
-
11.1.2 Medimmune Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Medimmune Measles Vaccine Main Business and Markets Served
-
11.1.4 Medimmune Measles Vaccine Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 CSL Limited
-
11.2.1 CSL Limited Company Details
-
11.2.2 CSL Limited Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 CSL Limited Measles Vaccine Main Business and Markets Served
-
11.2.4 CSL Limited Measles Vaccine Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 GSK
-
11.3.1 GSK Company Details
-
11.3.2 GSK Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 GSK Measles Vaccine Main Business and Markets Served
-
11.3.4 GSK Measles Vaccine Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Novartis
-
11.4.1 Novartis Company Details
-
11.4.2 Novartis Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Novartis Measles Vaccine Main Business and Markets Served
-
11.4.4 Novartis Measles Vaccine Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Bavarian Nordic
-
11.5.1 Bavarian Nordic Company Details
-
11.5.2 Bavarian Nordic Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Bavarian Nordic Measles Vaccine Main Business and Markets Served
-
11.5.4 Bavarian Nordic Measles Vaccine Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Merck
-
11.6.1 Merck Company Details
-
11.6.2 Merck Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Merck Measles Vaccine Main Business and Markets Served
-
11.6.4 Merck Measles Vaccine Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Pfizer
-
11.7.1 Pfizer Company Details
-
11.7.2 Pfizer Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Pfizer Measles Vaccine Main Business and Markets Served
-
11.7.4 Pfizer Measles Vaccine Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Serum Institute of India
-
11.8.1 Serum Institute of India Company Details
-
11.8.2 Serum Institute of India Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Serum Institute of India Measles Vaccine Main Business and Markets Served
-
11.8.4 Serum Institute of India Measles Vaccine Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 China National Biotech Group
-
11.9.1 China National Biotech Group Company Details
-
11.9.2 China National Biotech Group Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 China National Biotech Group Measles Vaccine Main Business and Markets Served
-
11.9.4 China National Biotech Group Measles Vaccine Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Emergent Biosolutions
-
11.10.1 Emergent Biosolutions Company Details
-
11.10.2 Emergent Biosolutions Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Emergent Biosolutions Measles Vaccine Main Business and Markets Served
-
11.10.4 Emergent Biosolutions Measles Vaccine Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Sanofi-Pasteur
-
11.11.1 Sanofi-Pasteur Company Details
-
11.11.2 Sanofi-Pasteur Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Sanofi-Pasteur Measles Vaccine Main Business and Markets Served
-
11.11.4 Sanofi-Pasteur Measles Vaccine Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Johnson & Johnson
-
11.12.1 Johnson & Johnson Company Details
-
11.12.2 Johnson & Johnson Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Johnson & Johnson Measles Vaccine Main Business and Markets Served
-
11.12.4 Johnson & Johnson Measles Vaccine Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Measles Vaccine Market Outlook by Types and Applications to 2028
-
12.1 Global Measles Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Mumps Measles Rubella Vaccine, Live (MMR-II) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Measles Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Adults Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Measles Vaccine Market Analysis and Outlook to 2028
-
13.1 Global Measles Vaccine Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Measles Vaccine Consumption Forecast (2022-2028)
-
13.2.2 Canada Measles Vaccine Consumption Forecast (2022-2028)
-
13.2.3 Mexico Measles Vaccine Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.2 UK Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.3 Spain Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.4 Belgium Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.5 France Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.6 Italy Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.7 Denmark Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.8 Finland Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.9 Norway Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.10 Sweden Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.11 Poland Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.12 Russia Measles Vaccine Consumption Forecast (2022-2028)
-
13.3.13 Turkey Measles Vaccine Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.2 Japan Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.3 India Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.4 South Korea Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.8 Thailand Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.9 Singapore Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.11 Philippines Measles Vaccine Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Measles Vaccine Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Measles Vaccine Consumption Forecast (2022-2028)
-
13.5.2 Colombia Measles Vaccine Consumption Forecast (2022-2028)
-
13.5.3 Chile Measles Vaccine Consumption Forecast (2022-2028)
-
13.5.4 Argentina Measles Vaccine Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Measles Vaccine Consumption Forecast (2022-2028)
-
13.5.6 Peru Measles Vaccine Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Measles Vaccine Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Measles Vaccine Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Measles Vaccine Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Measles Vaccine Consumption Forecast (2022-2028)
-
13.6.3 Oman Measles Vaccine Consumption Forecast (2022-2028)
-
13.6.4 Qatar Measles Vaccine Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Measles Vaccine Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Measles Vaccine Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Measles Vaccine Consumption Forecast (2022-2028)
-
13.7.2 South Africa Measles Vaccine Consumption Forecast (2022-2028)
-
13.7.3 Egypt Measles Vaccine Consumption Forecast (2022-2028)
-
13.7.4 Algeria Measles Vaccine Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Measles Vaccine Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Measles Vaccine Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Measles Vaccine
-
Figure of Measles Vaccine Picture
-
Table Global Measles Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Measles Vaccine Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Mumps Measles Rubella Vaccine, Live (MMR-II) Consumption and Growth Rate (2017-2022)
-
Figure Global Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Measles Vaccine Consumption by Country (2017-2022)
-
Table North America Measles Vaccine Consumption by Country (2017-2022)
-
Figure United States Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Canada Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Mexico Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Measles Vaccine Consumption by Country (2017-2022)
-
Figure Germany Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure UK Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Spain Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Belgium Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure France Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Italy Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Denmark Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Finland Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Norway Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Sweden Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Poland Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Russia Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Turkey Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Table APAC Measles Vaccine Consumption by Country (2017-2022)
-
Figure China Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Thailand Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Singapore Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Philippines Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Table South America Measles Vaccine Consumption by Country (2017-2022)
-
Figure Brazil Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Colombia Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Chile Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Argentina Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Peru Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Table GCC Measles Vaccine Consumption by Country (2017-2022)
-
Figure Bahrain Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Oman Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Qatar Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Table Africa Measles Vaccine Consumption by Country (2017-2022)
-
Figure Nigeria Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Africa Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Egypt Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Algeria Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Table Oceania Measles Vaccine Consumption by Country (2017-2022)
-
Figure Australia Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Measles Vaccine Consumption and Growth Rate (2017-2022)
-
Table Medimmune Company Details
-
Table Medimmune Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medimmune Measles Vaccine Main Business and Markets Served
-
Table Medimmune Measles Vaccine Product Portfolio
-
Table CSL Limited Company Details
-
Table CSL Limited Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Measles Vaccine Main Business and Markets Served
-
Table CSL Limited Measles Vaccine Product Portfolio
-
Table GSK Company Details
-
Table GSK Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Measles Vaccine Main Business and Markets Served
-
Table GSK Measles Vaccine Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Measles Vaccine Main Business and Markets Served
-
Table Novartis Measles Vaccine Product Portfolio
-
Table Bavarian Nordic Company Details
-
Table Bavarian Nordic Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bavarian Nordic Measles Vaccine Main Business and Markets Served
-
Table Bavarian Nordic Measles Vaccine Product Portfolio
-
Table Merck Company Details
-
Table Merck Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Measles Vaccine Main Business and Markets Served
-
Table Merck Measles Vaccine Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Measles Vaccine Main Business and Markets Served
-
Table Pfizer Measles Vaccine Product Portfolio
-
Table Serum Institute of India Company Details
-
Table Serum Institute of India Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute of India Measles Vaccine Main Business and Markets Served
-
Table Serum Institute of India Measles Vaccine Product Portfolio
-
Table China National Biotech Group Company Details
-
Table China National Biotech Group Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table China National Biotech Group Measles Vaccine Main Business and Markets Served
-
Table China National Biotech Group Measles Vaccine Product Portfolio
-
Table Emergent Biosolutions Company Details
-
Table Emergent Biosolutions Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emergent Biosolutions Measles Vaccine Main Business and Markets Served
-
Table Emergent Biosolutions Measles Vaccine Product Portfolio
-
Table Sanofi-Pasteur Company Details
-
Table Sanofi-Pasteur Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Pasteur Measles Vaccine Main Business and Markets Served
-
Table Sanofi-Pasteur Measles Vaccine Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Measles Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Measles Vaccine Main Business and Markets Served
-
Table Johnson & Johnson Measles Vaccine Product Portfolio
-
Figure Global Mumps Measles Rubella Vaccine, Live (MMR-II) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Measles Vaccine Consumption Forecast by Country (2022-2028)
-
Table North America Measles Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Measles Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Germany Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Measles Vaccine Consumption Forecast by Country (2022-2028)
-
Figure China Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Measles Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Brazil Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Measles Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Measles Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Measles Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Australia Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Measles Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
